Ethyl 2,4-dichloropyrimidine-5-carboxylate (CAS 51940-64-8)

Ethyl 2,4-dichloropyrimidine-5-carboxylate (CAS 51940-64-8) References

1. Synthetic studies on novel Syk inhibitors. Part 1: Synthesis and structure-activity relationships of pyrimidine-5-carboxamide derivatives.  |  Hisamichi, H., et al. 2005. Bioorg Med Chem. 13: 4936-51. PMID: 15990316
2. Synthesis and evaluation of 2-{[2-(4-hydroxyphenyl)-ethyl]amino}pyrimidine-5-carboxamide derivatives as novel STAT6 inhibitors.  |  Nagashima, S., et al. 2007. Bioorg Med Chem. 15: 1044-55. PMID: 17071093
3. Identification of 4-benzylamino-2-[(4-morpholin-4-ylphenyl)amino]pyrimidine-5-carboxamide derivatives as potent and orally bioavailable STAT6 inhibitors.  |  Nagashima, S., et al. 2008. Bioorg Med Chem. 16: 6509-21. PMID: 18534856
4. Structure-Guided Design of C4-alkyl-1,4-dihydro-2H-pyrimido[4,5-d][1,3]oxazin-2-ones as Potent and Mutant-Selective Epidermal Growth Factor Receptor (EGFR) L858R/T790M Inhibitors.  |  Hao, Y., et al. 2017. Sci Rep. 7: 3830. PMID: 28630494
5. Synthesis and biological evaluation of pyrimidine derivatives as novel human Pin1 inhibitors.  |  Cui, G., et al. 2018. Bioorg Med Chem. 26: 2186-2197. PMID: 29576270
6. Design, Synthesis, and Biological Evaluation of Pyrimido[4,5- d]pyrimidine-2,4(1 H,3 H)-diones as Potent and Selective Epidermal Growth Factor Receptor (EGFR) Inhibitors against L858R/T790M Resistance Mutation.  |  Hao, Y., et al. 2018. J Med Chem. 61: 5609-5622. PMID: 29906114
7. Discovery of Highly Selective Inhibitors of Calmodulin-Dependent Kinases That Restore Insulin Sensitivity in the Diet-Induced Obesity in Vivo Mouse Model.  |  Fromont, C., et al. 2020. J Med Chem. 63: 6784-6801. PMID: 32433887
8. Discovery, Optimization, and Structure-Activity Relationship Study of Novel and Potent RSK4 Inhibitors as Promising Agents for the Treatment of Esophageal Squamous Cell Carcinoma.  |  Yuan, Y., et al. 2021. J Med Chem. 64: 13572-13587. PMID: 34496560
9. Development of [18F]MIPS15692, a radiotracer with in vitro proof-of-concept for the imaging of MER tyrosine kinase (MERTK) in neuroinflammatory disease.  |  Wong, SW., et al. 2021. Eur J Med Chem. 226: 113822. PMID: 34563964
10. Identification of a Novel 2,8-Diazaspiro[4.5]decan-1-one Derivative as a Potent and Selective Dual TYK2/JAK1 Inhibitor for the Treatment of Inflammatory Bowel Disease.  |  Yang, T., et al. 2022. J Med Chem. 65: 3151-3172. PMID: 35113547
11. Bicyclic 6 + 6 systems: the chemistry of pyrimido[4,5-d]pyrimidines and pyrimido[5,4-d]pyrimidines.  |  Monier, M., et al. 2019. RSC Adv. 9: 30835-30867. PMID: 35558733
12. Pyrimido[4,5-d]pyrimidin-4(1H)-one Derivatives as Selective Inhibitors of EGFR Threonine790 to Methionine790 (T790M) Mutants  |  Xu, T., Zhang, L., Xu, S., Yang, C. Y., Luo, J., Ding, F.,.. & Ding, K. 2013. Angewandte Chemie. 125(32): 8545-8548.
13. The Discovery of 7-Methyl-2-[(7-methyl[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino]-9-(tetrahydro-2H-pyran-4-yl)-7,9-dihydro-8H-purin-8-one (AZD7648), a Potent and Selective DNA-Dependent Protein Kinase (DNA-PK) Inhibitor  |  Goldberg, F. W., Finlay, M. R. V., Ting, A. K., Beattie, D., Lamont, G. M., Fallan, C.,.. & Dean, E. 2019. J. Med. Chem. 63(7): 3461–3471.